Kenon Holdings Reports Full Year 2023 Results and Additional Updates Singapore, March 26, 2024. Kenon Holdings Ltd. announces its results for 2023 and additional.
Rocket Pharmaceuticals, Inc. , a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today announced the appointment of Aaron Ondrey, as Chief Financial.
Kenon Holdings Reports Q3 2023 Results and Additional Updates Singapore, November 29, 2023. Kenon Holdings Ltd. announces its results for Q3 2023 and additional.